← Dashboard
Nov 02, 2026 12:23 PM ET
Signal
Corporate
Krystal Biotech GAAP EPS of $2.05 beats by $0.28, revenue of $1.1B beats by $973.46M
Krystal Biotech EPS beat by $0.28 and revenue beat by $973.46M.
What changed
Krystal Biotech EPS beat by $0.28 and revenue beat by $973.46M.
Why it matters
Krystal Biotech EPS beat by $0.28 and revenue beat by $973.46M. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →